The European Society of Human Reproduction and Embryology guideline for the diagnosis and treatment of endometriosis: an electronic guideline implementability appraisal
1 Department of Obstetrics & Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
2 Department of Obstetrics & Gynaecology, University Fertility Center, Gasthuisberg University Hospital, Leuven, Belgium
3 Department of Obstetrics & Gynaecology, Maastricht University Medical Centre and Research Institute GROW, Maastricht University, Maastricht, The Netherlands
4 Scientific Institute for Quality of Healthcare and Dutch Institute for Healthcare Improvement CBO, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
5 Department of Obstetrics & Gynaecology, Institution of Clinical Sciences, Sahlgrenska Academy, Göteborg University, Göteberg, Sweden
6 IVF Clinic, Queen Sophia Hospital, Stockholm, Sweden
7 Department of Obstetrics & Gynaecology, University Medical Centre, Groningen, The Netherlands
8 Department of Obstetrics & Gynaecology, Infertility Centre, Gent University Hospital, Gent, Belgium
9 Independent Guideline Adviser, New Zealand
Implementation Science 2011, 6:7 doi:10.1186/1748-5908-6-7Published: 19 January 2011
Clinical guidelines are intended to improve healthcare. However, even if guidelines are excellent, their implementation is not assured. In subfertility care, the European Society of Human Reproduction and Embryology (ESHRE) guidelines have been inventoried, and their methodological quality has been assessed. To improve the impact of the ESHRE guidelines and to improve European subfertility care, it is important to optimise the implementability of guidelines. We therefore investigated the implementation barriers of the ESHRE guideline with the best methodological quality and evaluated the used instrument for usability and feasibility.
We reviewed the ESHRE guideline for the diagnosis and treatment of endometriosis to assess its implementability. We used an electronic version of the guideline implementability appraisal (eGLIA) instrument. This eGLIA tool consists of 31 questions grouped into 10 dimensions. Seven items address the guideline as a whole, and 24 items assess the individual recommendations in the guideline. The eGLIA instrument identifies factors that influence the implementability of the guideline recommendations. These factors can be divided into facilitators that promote implementation and barriers that oppose implementation. A panel of 10 experts from three European countries appraised all 36 recommendations of the guideline. They discussed discrepancies in a teleconference and completed a questionnaire to evaluate the ease of use and overall utility of the eGLIA instrument.
Two of the 36 guideline recommendations were straightforward to implement. Five recommendations were considered simply statements because they contained no actions. The remaining 29 recommendations were implementable with some adjustments. We found facilitators of the guideline implementability in the quality of decidability, presentation and formatting, apparent validity, and novelty or innovation of the recommendations. Vaguely defined actions, lack of facilities, immeasurable outcomes, and inflexibility within the recommendations formed barriers to implementation. The eGLIA instrument was generally useful and easy to use. However, assessment with the eGLIA instrument is very time-consuming.
The ESHRE guideline for the diagnosis and treatment of endometriosis could be improved to facilitate its implementation in daily practice. The eGLIA instrument is a helpful tool for identifying obstacles to implementation of a guideline. However, we recommend a concise version of this instrument.